Table 1.
Relationship between Bax expression, Bcl-2 expression the expression of VEGF, Cytochrome-c, Caspase-3, or MMP-9 and T stage or N stage
| Patients (n) | VEGF | Cy-c | Casp-3 | MMP-9 | Bax expression | Bcl-2 expression | |
|---|---|---|---|---|---|---|---|
| |
|
|
|
|
|
<10%--->10% |
<10%--->10% |
| T0 |
7 |
129.7 ± 67.7 |
68.3 ± 54.6 |
0.22 ± 0.1 |
488.6 ± 405.1 |
1(14)----6(86) |
4(29)-----3(20) |
| T2-T3 |
22 |
516.51 ± 69.63 |
54.48 ± 28.85 |
0.07 ± 0.043 |
1166.6 ± 745.9 |
18(82)--4(18) |
10(71)---12(80) |
| P value |
|
0.051 |
0.72 |
0.19 |
0.04 |
0.001 |
0.59 |
| |
|
|
|
|
|
<10%--->10% |
<10%--->10% |
| No |
19 |
381.4 ± 631.1 |
61.2 ± 38.6 |
0.12 ± 0.2 |
991.4 ± 803.6 |
11(58)---8(42) |
10(71)---9(60) |
| N(+) |
10 |
528.67 ± 531.40 |
50.28 ± 28.15 |
0.06 ± 0.47 |
1064.97 ± 620.8 |
8(80)-----2(20) |
4(29)-----6(40) |
| P value | 0.20 | 0.68 | 0.21 | 0.50 | 0.23 | 0.52 |
Units: VEGF, pg/ml; Cy-c: Cytochrome-c, ng/ml; Casp-3: Caspase-3, pmol AMC/min/mg; MMP-9, ng/ml.
*Numbers in parentheses indicate percentages.